| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Agios Pharmaceuticals, Inc. (AGIO) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 29 sells. AGIO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 149.1K | $5.30M | - | |
| Other | 67.7K | $2.41M | - | |
| CFO | 40.3K | $1.44M | - | |
| Other | 34.6K | $1.23M | - | |
| Dir | 17.8K | $633.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 10, 2016 | Biller Scott | Chief Scientific Officer | Sell | 5,000 | $60.00 | $300,000.00 | -17.2% | |
| Oct 27, 2016 | Cantley Lewis Clayton Jr. | Director | Sell | 2,504 | $48.94 | $122,545.76 | -0.6% | |
| Oct 5, 2016 | Biller Scott | Chief Scientific Officer | Sell | 5,000 | $55.00 | $275,000.00 | -23.8% | |
| Sep 28, 2016 | Cantley Lewis Clayton Jr. | Director | Sell | 2,504 | $54.07 | $135,403.80 | -0.6% | |
| Sep 20, 2016 | Biller Scott | Chief Scientific Officer | Sell | 5,000 | $50.00 | $250,000.00 | -19.2% | |
| Aug 30, 2016 | Cantley Lewis Clayton Jr. | Director | Sell | 2,504 | $37.31 | $93,424.24 | -0.6% | |
| Jul 26, 2016 | Cantley Lewis Clayton Jr. | Director | Sell | 2,504 | $42.79 | $107,158.68 | -0.6% | |
| Jun 28, 2016 | Cantley Lewis Clayton Jr. | Director | Sell | 2,504 | $41.88 | $104,855.00 | -0.5% | |
| Jun 8, 2016 | Biller Scott | Chief Scientific Officer | Sale+OE | 27,500 | $65.00 | $1,787,500.00 | -31.8% | |
| May 26, 2016 | Cantley Lewis Clayton Jr. | Director | Sell | 2,504 | $51.69 | $129,431.76 | -0.5% |